CPH creso pharma limited

News: CPH Creso Pharma Posts HY Revenue From Ordinary Activities A$4.3 Million

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    Aug 31 (Reuters) - Creso Pharma Ltd (CPH) :

    • HY REVENUE FROM ORDINARY ACTIVITIES A$4.3 MILLION VERSUS A$3 MILLION
    • HY NET LOSS ATTRIBUTABLE A$7.1 MILLION VERSUS LOSS OF A$19.0 MILLION
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.